Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefepime vs Ceftriaxone for Nursing Home Pneumonia
NCT00358202Phase 4Completed
- Sponsor
- CPL Associates
- Start
- Mar 2002
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of cefepime in pneumonia (2 arms), sponsored by CPL Associates. Primary endpoint: Total cost of all antibiotics. Started Mar 2002; status: completed.
02
Drugs
cefepime
03
Conditions
pneumonia
Beyond the preview
Go deeper on NCT00358202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00358202.